Searched for: person:caplaa01
in-biosketch:yes
Trump's statements about acetaminophen and the problem of epistemic corrections
Germani, Federico; Spitale, Giovanni; Caplan, Arthur L
PMID: 41672756
ISSN: 2515-4478
CID: 6002312
The United States platelet shortage: Whole blood derived platelets or paying donors
Caplan, Arthur; McCullough, Jeffrey
PMID: 41643225
ISSN: 1473-0502
CID: 6000422
Is concurrent gestational surrogacy an ethical practice?
Feinberg, Eve C; Bayefsky, Michelle J; Copperman, Alan; Caplan, Arthur; Violette, Caroline; Hipp, Heather S; Kawwass, Jennifer F
PMID: 41547651
ISSN: 1556-5653
CID: 5986872
Public Health Policymaking Outside of the Federal Government: Reflections on Authority and Trust-Building Challenges [Editorial]
Taylor, Lauren A; Caplan, Arthur L
PMCID:12696972
PMID: 41370771
ISSN: 1541-0048
CID: 5977422
Is informed consent correctly obtained for vaccinations?
Jagadish, Dhriti; Mamo, Nathaniel; Pasadyn, Felicia; Caplan, Arthur
Informed consent is an integral tenet of medical ethics. However, the United States lacks a standardized consent process for immunizations, with states and private companies instead reliant on Vaccine Information Statements (VISs) introduced by the 1986 National Childhood Vaccine Injury Act. VISs, rather than being developed with patient autonomy in mind, were a response to excessive vaccine injury litigation and resulting vaccine supply shortages. VISs do not provide meaningful information disclosures, with its producer - the Centers for Disease Control and Prevention - itself admitting that VISs should not be mistaken for informed consent forms. In its content, the VIS is too complex in its readability, does not situate immunization in a public health context, and does not present all alternatives. VIS delivery is also inadequate, with limited time given for patients to digest vaccine information and no documentation required to ensure that VISs were presented at all. Simply put, VISs do little to spark deliberation and increase vaccine confidence. This article recommends minor improvements to VIS content, delivery, and accountability mechanisms to ensure distribution. The authors argue that these patient-provider moments - for patients to better understand their health, the threat of disease, and the weight of their contribution to the public - should not be squandered.
PMCID:11834450
PMID: 39956634
ISSN: 2164-554x
CID: 5842962
SPIRIT 2025 and CONSORT 2025 Statements: Guidance Tools to Ensure Clinical Trial Transparency [Editorial]
Dal-RĂ©, Rafael; Caplan, Arthur L
PMID: 40494683
ISSN: 1579-2129
CID: 5869172
The Responsible Development of Adeno-Associated Virus Gene Therapies
Wilson, James M; Caplan, Arthur L
Several unexpected fatalities in patients who received adeno-associated virus (AAV)-based gene therapies have recently occurred. These tragic events have cast a pall over the entire sector with some stakeholders suggesting that AAV is patently unsafe as a gene delivery platform and ought not to be pursued. This conclusion is not warranted.
PMID: 40643951
ISSN: 1557-7422
CID: 5891232
Vaccinations for allFair Doses Seth Berkley University of California Press, 2025. 408 pp
Caplan, Arthur
An epidemiologist advocates for vaccine equity.
PMID: 41129648
ISSN: 1095-9203
CID: 5957132
Should scientists be allowed to bring distant human ancestors back to life?
Caplan, Arthur L
Recent efforts by a private company to modify modern species with ancient DNA in the name of 'de-extinction' are both scientifically and morally suspect. A bright line requiring more than press releases as well as independent ethical oversight must be drawn before they are extended to distant human and hominid ancestors.
PMCID:12419627
PMID: 40906789
ISSN: 1545-7885
CID: 5936342
How stupid has science been?
Caplan, Arthur
PMID: 40859017
ISSN: 1469-3178
CID: 5910112